Please find biological processes in the following text map to GO id possible 
return results as  

span: GO term

OR 

span: no_match 

If no matching go term is found

TEXT:

Based on my comprehensive research, I can now provide a detailed analysis of the gene list enriched in astrocyte precursor cells from glioblastoma samples. The genes suggest several key cellular processes and states that provide insight into the biology of these cancer cells.

# Gene Expression Profile Analysis: Astrocyte Precursor Cell-Type in Glioblastoma

## Overview

The gene list ['POSTN', 'JPH1', 'EYA4', 'RTN1', 'LAMA2', 'AC092957.1', 'TNC', 'IGFBP7', 'COL23A1', 'NAMPT'] from astrocyte precursor cells in glioblastoma samples reveals a complex cellular state characterized by **extracellular matrix remodeling**, **metabolic stress adaptation**, **calcium dysregulation**, and **enhanced invasive potential**. This expression profile suggests cells undergoing epithelial-mesenchymal transition (EMT)-like processes while maintaining stem cell characteristics.

## Key Biological Processes and States

### **1. Extracellular Matrix Remodeling and Invasion**

**Primary genes involved:** POSTN, TNC, LAMA2, COL23A1

**Process description:** These cells exhibit extensive ECM remodeling capabilities, facilitating invasion and metastasis[1][2]. **POSTN (periostin)** acts as a matricellular protein that promotes cancer cell survival, EMT, invasion, and metastasis through integrin receptor interactions[1]. In glioblastoma specifically, POSTN promotes stem cell self-renewal via the αVβ3/PI3K/AKT/β-catenin/FOSL1 pathway while recruiting immunosuppressive microglia[3]. **TNC (tenascin-C)** is an ECM glycoprotein that promotes cell migration and invasion, while **LAMA2** encodes laminin alpha-2, a critical basement membrane component[4].

**Required genes for this function:**
- **Integrin signaling pathway**: ITGA1, ITGA8, ITGAV, ITGB1, ITGB3, FERMT2[5]
- **FAK signaling**: PTK2 (FAK), SRC, BCAR1
- **ECM remodeling**: MMP2, MMP9, TIMP1, TIMP2, COL1A1, COL4A1
- **PI3K/AKT pathway**: PIK3CA, PIK3R1, AKT1, AKT2, MTOR, PTEN[6][7]

### **2. Epithelial-Mesenchymal Transition (EMT)**

**Primary genes involved:** POSTN, TNC, IGFBP7

**Process description:** The gene signature indicates active EMT processes, essential for cancer cell plasticity and invasion[1]. POSTN specifically promotes EMT through integrin-FAK-STAT3 signaling[8], while contributing to the aggressive phenotype characteristic of glioblastoma stem cells.

**Required genes for this function:**
- **EMT transcription factors**: SNAI1 (SNAIL), SNAI2 (SLUG), TWIST1, ZEB1, ZEB2[9][10][11]
- **Signaling pathways**: STAT3, SMAD2, SMAD3, TGFB1, WNT3A, GSK3B
- **Cell adhesion loss**: CDH1 (E-cadherin), CDH2 (N-cadherin), VIM (vimentin)

### **3. Calcium Homeostasis Dysregulation and ER Stress**

**Primary genes involved:** JPH1, RTN1

**Process description:** **JPH1 (junctophilin-1)** is critical for calcium signaling between the endoplasmic reticulum and plasma membrane, forming SR-PM junctions essential for voltage-induced calcium release[12][13]. **RTN1 (reticulon-1)** shapes ER tubular domains and regulates ER homeostasis and autophagy[4]. Dysregulation of these genes suggests compromised calcium homeostasis, which can promote cancer cell survival and resistance to cell death[14][15].

**Required genes for this function:**
- **Calcium channels**: CACNA1C, CACNA1S, RYR1, RYR2, IP3R1 (ITPR1), IP3R2, IP3R3
- **Calcium signaling**: CAMK2A, CAMK2B, CALR, CANX, GRP78 (HSPA5)
- **ER stress response**: XBP1, ATF4, ATF6, IRE1 (ERN1), PERK (EIF2AK3), CHOP (DDIT3)[14]
- **Calcium pumps**: ATP2A1 (SERCA1), ATP2A2 (SERCA2), ATP2B1[16]

### **4. Metabolic Stress Adaptation**

**Primary genes involved:** NAMPT, IGFBP7

**Process description:** **NAMPT (nicotinamide phosphoribosyltransferase)** is the rate-limiting enzyme in NAD+ biosynthesis, crucial for cancer cell energy metabolism[17][18]. Cancer cells preferentially utilize the NAD+ salvage pathway for survival, making NAMPT essential for glioma proliferation[19]. **IGFBP7** acts as a senescence marker and stress response regulator[20][21].

**Required genes for this function:**
- **NAD+ metabolism**: PARP1, SIRT1, SIRT3, SIRT6, NMNAT1, NMNAT2
- **Glycolysis**: HK1, HK2, PFKM, ALDOA, GAPDH, PKM, LDHA
- **Oxidative phosphorylation**: NDUFA1, SDHA, COX4I1, ATP5A1
- **Stress response**: HIF1A, NRF2 (NFE2L2), SOD1, SOD2, CAT[22][18]

### **5. Cell Cycle Control and DNA Repair**

**Primary genes involved:** EYA4, NAMPT

**Process description:** **EYA4 (eyes absent 4)** functions as a tyrosine phosphatase essential for PLK1 activation and successful mitosis[23][24]. It dephosphorylates PLK1 at Y445, enabling centrosome maturation and proper cell division. NAMPT supports DNA repair processes through NAD+ provision for PARP1 activity[25].

**Required genes for this function:**
- **Cell cycle regulators**: PLK1, BORA, CEP192, CCND1, CCNE1, CDK1, CDK2
- **DNA damage response**: ATM, ATR, BRCA1, BRCA2, TP53, MDM2
- **Checkpoint control**: CHEK1, CHEK2, WEE1, CDC25A
- **Mitotic machinery**: AURKB, BUB1, MAD2L1, CENPA[23]

### **6. Cellular Senescence and Stress Response**

**Primary genes involved:** IGFBP7, NAMPT

**Process description:** IGFBP7 is a key component of the senescence-associated secretory phenotype (SASP), linking aging and cancer progression[20]. It promotes cardiac senescence through IGF-1R/IRS/AKT-dependent suppression of FOXO3a[21]. In cancer contexts, senescence can be bypassed, allowing continued proliferation.

**Required genes for this function:**
- **Senescence markers**: CDKN1A (p21), CDKN2A (p16), RB1, FOXO3A
- **SASP factors**: IL6, IL8, CXCL1, CCL2, MMP3
- **Stress signaling**: MAPK14 (p38), JNK1, FOXO1, FOXO4
- **Telomere maintenance**: TERT, TERC, TERF1, TERF2[21]

## Cell-Cell Interactions and Microenvironment

### **Immune Modulation**
POSTN recruits immunosuppressive microglia and promotes regulatory T cell development through PI3K/AKT/NFκB signaling[3]. This creates an immunosuppressive tumor microenvironment that facilitates glioblastoma progression.

**Required genes**: CD70, TGFB1, IL10, IDO1, PD-L1 (CD274), CTLA4, FOXP3

### **Angiogenesis and Vascular Remodeling**
The ECM remodeling genes (POSTN, TNC) and metabolic factors (IGFBP7) contribute to angiogenesis regulation[26].

**Required genes**: VEGFA, VEGFR2 (KDR), ANGPT1, ANGPT2, TIE2 (TEK), PDGFB

### **Cancer-Associated Fibroblast Interactions**
POSTN can be secreted by cancer-associated fibroblasts, promoting cancer cell proliferation through paracrine signaling[8].

**Required genes**: α-SMA (ACTA2), FAP, COL1A1, PDGFRA, CAV1

## Clinical and Therapeutic Implications

This gene expression profile suggests **highly aggressive glioblastoma cells** with enhanced invasive capabilities, metabolic flexibility, and resistance to therapy. The combination of ECM remodeling, EMT activation, and metabolic reprogramming indicates cells poised for invasion and metastasis while maintaining stem cell characteristics.

**Potential therapeutic targets** include:
- NAMPT inhibitors for metabolic disruption[17][19]
- Integrin antagonists targeting POSTN-mediated signaling[1][3]
- Calcium channel modulators for JPH1/RTN1 pathways
- EMT inhibitors targeting transcription factors
- PI3K/AKT/mTOR pathway inhibitors[6][27]

The presence of these genes in astrocyte precursor cells suggests they represent a **transition state** between normal astrocyte precursors and fully transformed glioblastoma stem cells, making them critical targets for early intervention strategies.

[1] https://cancerci.biomedcentral.com/articles/10.1186/s12935-022-02714-8
[2] https://www.frontiersin.org/articles/10.3389/fonc.2021.795712/full
[3] https://cco.amegroups.com/article/view/127607/html
[4] https://elifesciences.org/articles/51918
[5] http://www.europeanreview.org/article/28615
[6] https://vavilov.elpub.ru/jour/article/view/3861
[7] https://www.spandidos-publications.com/10.3892/or.2014.3101
[8] https://www.thno.org/v14p3014.htm
[9] https://onlinelibrary.wiley.com/doi/10.1111/jop.12065
[10] http://biorxiv.org/lookup/doi/10.1101/2023.02.03.526978
[11] https://onlinelibrary.wiley.com/doi/10.1155/2016/5285892
[12] https://rupress.org/jgp/article/154/9/e2021ecc22/212780/Voltage-induced-Ca2-release-is-supported-by
[13] https://www.science.org/doi/10.1126/science.aan3303
[14] http://www.hindawi.com/journals/bmri/2015/352794/
[15] https://www.mdpi.com/2079-7737/11/6/811
[16] https://www.mdpi.com/1422-0067/25/4/2148
[17] https://www.tandfonline.com/doi/full/10.1080/13543776.2024.2367006
[18] https://linkinghub.elsevier.com/retrieve/pii/S0021925820350754
[19] https://academic.oup.com/neuro-oncology/article/26/Supplement_8/viii307/7890686
[20] https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14120
[21] https://www.nature.com/articles/s44161-022-00181-y
[22] https://aacrjournals.org/mct/article/22/12_Supplement/A105/730728/Abstract-A105-Pharmacological-inhibition-of
[23] https://www.nature.com/articles/s41467-024-45683-4
[24] http://biorxiv.org/lookup/doi/10.1101/2022.10.10.511510
[25] https://www.mdpi.com/1420-3049/29/12/2836
[26] https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.4c00983
[27] https://cancerci.biomedcentral.com/articles/10.1186/s12935-023-03073-8
[28] https://www.mdpi.com/2073-4409/10/4/892
[29] https://www.aging-us.com/lookup/doi/10.18632/aging.204056
[30] https://onlinelibrary.wiley.com/doi/10.1002/jcp.29184
[31] http://biorxiv.org/lookup/doi/10.1101/2021.12.17.473115
[32] http://link.springer.com/10.1007/s10048-006-0034-4
[33] https://www.nature.com/articles/s41419-022-04757-1
[34] https://pubs.acs.org/doi/10.1021/acs.jafc.2c02824
[35] https://journals.asm.org/doi/10.1128/mBio.01615-21
[36] https://www.nature.com/articles/s41586-023-06089-2
[37] https://xlink.rsc.org/?DOI=D4FO00783B
[38] https://academic.oup.com/hmg/article/31/16/2779/6553888
[39] https://karger.com/article/doi/10.1159/000531641
[40] https://link.springer.com/10.1007/s00438-023-02016-2
[41] https://link.springer.com/10.1007/s12288-023-01701-x
[42] https://academic.oup.com/carcin/article/doi/10.1093/carcin/bgaf020/8113362
[43] https://linkinghub.elsevier.com/retrieve/pii/S0016508524042148
[44] https://www.nature.com/articles/s41598-022-14320-9
[45] https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.110.958694
[46] https://www.micropublication.org/journals/biology/micropub-biology-001323
[47] https://royalsocietypublishing.org/doi/10.1098/rsif.2014.0570
[48] https://www.semanticscholar.org/paper/7015edb9d184b2fe20a20306178f33edb4c31221
[49] https://www.semanticscholar.org/paper/fae8888a1fa3ee2d1900fd1962bbdf1b439d064c
[50] https://www.semanticscholar.org/paper/f5db7c7f46b5f9dc8ed658efd105102f943b2e38
[51] https://publish.kne-publishing.com/index.php/ACTA/article/view/1874
[52] https://academic.oup.com/ibdjournal/article/19/10/2079-2083/4602988
[53] https://journals.lww.com/00029330-201606050-00016
[54] https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/8.1.11
[55] https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00467
[56] https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c01954
[57] https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00077
[58] https://www.nature.com/articles/cdd201244
[59] https://academic.oup.com/neuro-oncology/article/22/Supplement_2/ii200/5961299
[60] https://academic.oup.com/neuro-oncology/article/23/Supplement_6/vi174/6427104
[61] https://www.mdpi.com/2073-4409/12/9/1290
[62] https://www.mdpi.com/2073-4409/11/14/2128
[63] https://aacrjournals.org/cancerres/article/83/6/807/718567/Primitive-Oligodendrocyte-Precursor-Cells-Are
[64] https://rupress.org/jem/article/214/10/2843/42255/Zika-virus-has-oncolytic-activity-against
[65] https://www.mdpi.com/2073-4409/11/23/3923
[66] https://onlinelibrary.wiley.com/doi/10.1002/smll.202403201
[67] https://linkinghub.elsevier.com/retrieve/pii/S0022227520346320
[68] https://academic.oup.com/jpp/article/75/5/645/7086141
[69] https://www.mdpi.com/1660-3397/18/1/45
[70] https://pubs.acs.org/doi/10.1021/acsnano.4c11455
[71] https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-025-03356-4
[72] https://onlinelibrary.wiley.com/doi/10.1002/ijc.30545
[73] https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-015-0579-y
[74] https://www.nature.com/articles/s41388-018-0252-x
[75] https://www.nature.com/articles/jhg201635
[76] https://www.degruyter.com/document/doi/10.2478/s11658-012-0011-x/html
[77] https://www.nature.com/articles/s41388-019-1134-6
[78] https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.2282
[79] http://link.springer.com/10.1007/s00428-009-0771-5
[80] http://link.springer.com/10.1007/s13105-019-00716-1
[81] https://link.springer.com/10.1007/s10549-025-07723-5
[82] https://www.aeurologia.com/EN/10.56434/j.arch.esp.urol.20257803.39
[83] http://www.dl.begellhouse.com/journals/6dbf508d3b17c437,3b40abcc31226ddb,3bebf37458d789dd.html
[84] https://journals.lww.com/02223309-201643001-00015
[85] https://www.frontiersin.org/articles/10.3389/fimmu.2022.877650/full
[86] https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.7418
[87] https://www.nature.com/articles/s41419-021-03588-w
[88] https://www.mdpi.com/1424-8247/15/3/307
[89] https://onlinelibrary.wiley.com/doi/10.1002/path.4747
[90] http://link.springer.com/10.1007/s11033-009-9721-1
[91] https://onlinelibrary.wiley.com/doi/10.1111/tan.12410
[92] https://www.science.org/doi/10.1126/science.abq5209
[93] https://academic.oup.com/carcin/article/42/11/1314/6380882
[94] https://dx.plos.org/10.1371/journal.pone.0143628
[95] https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP281480
[96] https://www.sciencemag.org/lookup/doi/10.1126/science.362.6421.1372-j
[97] https://aacrjournals.org/cebp/article/14/4/830/258339/Frequent-Methylation-of-Eyes-Absent-4-Gene-in
[98] https://www.semanticscholar.org/paper/9c821f63a4516177d45943946b77ba11c4cb0160
[99] https://aacrjournals.org/cancerres/article/77/14/3857/622756/Nicotinic-Acid-Phosphoribosyltransferase-Regulates
[100] https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268756/full
[101] https://www.nature.com/articles/s41392-021-00491-w
[102] https://stemcellres.biomedcentral.com/articles/10.1186/s13287-021-02231-x
[103] https://www.science.org/doi/10.1126/scisignal.ads6550
[104] https://www.nature.com/articles/cddis2014427
[105] https://www.ijbs.com/v17p1395.htm
[106] https://pmc.ncbi.nlm.nih.gov/articles/PMC3039529/
[107] https://aacrjournals.org/cancerres/article/78/13_Supplement/2013/626349/Abstract-2013-microRNAs-targeting-EMT
[108] https://www.dovepress.com/inhibition-of-migration-invasion-and-drug-resistance-of-pancreatic-ade-peer-reviewed-article-OTT
[109] https://www.eurekaselect.com/219325/article
[110] https://www.hindawi.com/journals/ecam/2019/7517431/